A partially observable Markov chain framework to estimate overdiagnosis risk in breast cancer screening: Incorporating uncertainty in patients adherence behaviors-Reference-Cited by-同舟云学术

A partially observable Markov chain framework to estimate overdiagnosis risk in breast cancer screening: Incorporating uncertainty in patients adherence behaviors

Published:2019-12 Issue: Volume:89 Page:40-53
ISSN:0305-0483
Container-title:Omega
language:en
Short-container-title:Omega

Author:

Molani Sevda^ORCID,Madadi Mahboubeh,Wilkes Wesley

Publisher

Elsevier BV

Subject

Information Systems and Management,Management Science and Operations Research,Strategy and Management

Reference49 articles.

1. Explaining the difference in prognosis between screen-detected and symptomatic breast cancers;Allgood;Br J Cancer,2011

2. American Cancer Society. Lifetime Risk of Developing or Dying From Cancer. https://www.cancer.org/cancer/cancer-basics/lifetime-probability-of-developing-or-dying-from-cancer.html; 2011. (Accessed 28-December-2017).

3. American Cancer Society. Breast Cancer Facts and Figures 2015–2016. 2015. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2015-2016.pdf.

4. American Cancer Society. Breast Cancer Facts and Figures 2017–2018. 2017c. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2017-2018.pdf.

5. American Cancer Society. How Common is Breast Cancer. 2017a. https://www.cancer.org/cancer/breast-cancer/about/how-common-is-breast-cancer.html, (Accessed 30-January-2018).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data-driven overdiagnosis definitions: A scoping review;Journal of Biomedical Informatics;2023-11

2. Polyvinyl Alcohol (PVA)-Based Nanoniosome for Enhanced in vitro Delivery and Anticancer Activity of Thymol;International Journal of Nanomedicine;2023-06

3. Nanocomposite of reduced nanographene oxide with β-lactoglobulin protein (rNGO/β-Lg) as a carrier of the anticancer drug oxaliplatin (Eloxatin);Diamond and Related Materials;2023-06

4. A multi-objective constrained partially observable Markov decision process model for breast cancer screening;Operational Research;2023-04-29

5. Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy;International Journal of Biological Macromolecules;2023-04